Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial

Background: To evaluate the efficacy, safety and tolerability of methylphenidate (MPH) for cognitive function in older patients with mild cognitive impairment (MCI). Methods: Male and female subjects aged 65 years and older with a clinical diagnosis MCI were included in an exploratory randomized, do...

Descripción completa

Detalles Bibliográficos
Autores principales: Press, Yan, Punchik, Boris, Kagan, Ella, Berzak, Alexander, Freud, Tamar, Dwolatzky, Tzvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900434/
https://www.ncbi.nlm.nih.gov/pubmed/33634145
http://dx.doi.org/10.3389/fmed.2021.594228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900434/
https://www.ncbi.nlm.nih.gov/pubmed/33634145
http://dx.doi.org/10.3389/fmed.2021.594228

Ejemplares similares